Literature DB >> 9893840

M- and L-cones in early infancy: III. Comparison of genotypic and phenotypic markers of color vision in infants and adults.

M L Bieber1, J S Werner, K Knoblauch, J Neitz, M Neitz.   

Abstract

Genetic analyses were performed on five male children (approximately 3 years), two suspect color-normals and three suspects for congenital color vision deficiencies. These classifications were based on visually-evoked potential (VEP) responses to M- and L-cone-isolating stimuli obtained in a previous study when each subject was either 4- or 8-weeks old. The present analyses were performed in a blind study to characterize the genotypes of these subjects. Four male adults with various color vision phenotypes were also tested as a control. DNA was isolated using a non-invasive technique followed by polymerase chain reaction (PCR) amplification and restriction enzyme analysis to examine the genomic DNA of each subject. The genetic analyses confirmed the VEP identification of two color defective infants, and were consistent with the diagnosis of two other infants as color normal. A third infant was predicted by VEP analysis to have a protan defect, but he did not have a gene array typically found in protan observers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893840     DOI: 10.1016/s0042-6989(98)00067-4

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  2 in total

Review 1.  The Verriest Lecture: Short-wave-sensitive cone pathways across the life span.

Authors:  John S Werner
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2016-03       Impact factor: 2.129

2.  Psychophysical Evaluation of Congenital Colour Vision Deficiency: Discrimination between Protans and Deutans Using Mollon-Reffin's Ellipses and the Farnsworth-Munsell 100-Hue Test.

Authors:  Natáli Valim Oliver Bento-Torres; Anderson Raiol Rodrigues; Maria Izabel Tentes Côrtes; Daniela Maria de Oliveira Bonci; Dora Fix Ventura; Luiz Carlos de Lima Silveira
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.